These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29569837)

  • 1. Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant Women.
    Dallmann A; Solodenko J; Ince I; Eissing T
    CPT Pharmacometrics Syst Pharmacol; 2018 Jul; 7(7):419-431. PubMed ID: 29569837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.
    Kuepfer L; Niederalt C; Wendl T; Schlender JF; Willmann S; Lippert J; Block M; Eissing T; Teutonico D
    CPT Pharmacometrics Syst Pharmacol; 2016 Oct; 5(10):516-531. PubMed ID: 27653238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Pediatric Modeling and Simulation Using Ontogeny Information.
    Ince I; Solodenko J; Frechen S; Dallmann A; Niederalt C; Schlender J; Burghaus R; Lippert J; Willmann S
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S95-S103. PubMed ID: 31502689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically Based Pharmacokinetic Modeling of Renally Cleared Drugs in Pregnant Women.
    Dallmann A; Ince I; Solodenko J; Meyer M; Willmann S; Eissing T; Hempel G
    Clin Pharmacokinet; 2017 Dec; 56(12):1525-1541. PubMed ID: 28391404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Systems Pharmacology and Physiologically-Based Pharmacokinetic Modeling With mrgsolve: A Hands-On Tutorial.
    Elmokadem A; Riggs MM; Baron KT
    CPT Pharmacometrics Syst Pharmacol; 2019 Dec; 8(12):883-893. PubMed ID: 31652028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. When special populations intersect with drug-drug interactions: Application of physiologically-based pharmacokinetic modeling in pregnant populations.
    Sychterz C; Galetin A; Taskar KS
    Biopharm Drug Dispos; 2021 Apr; 42(4):160-177. PubMed ID: 33759451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Greater Insights on Applications of Modeling and Simulation in Pregnancy.
    Song L; Cui C; Zhou Y; Dong Z; Yu Z; Xu Y; Zhou T; Abduljalil K; Han H; Li L; Yang J; Zhao Y; Li H; Liu D
    Curr Drug Metab; 2020; 21(9):722-741. PubMed ID: 32895038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Verification of a Linked
    Patilea-Vrana GI; Unadkat JD
    Drug Metab Dispos; 2021 Jul; 49(7):509-520. PubMed ID: 33952608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of a PBPK model to predict disposition in pregnant women of drugs cleared via multiple CYP enzymes, including CYP2B6, CYP2C9 and CYP2C19.
    Ke AB; Nallani SC; Zhao P; Rostami-Hodjegan A; Unadkat JD
    Br J Clin Pharmacol; 2014 Mar; 77(3):554-70. PubMed ID: 23834474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically-Based Pharmacokinetic Modeling of Tenofovir Disoproxil Fumarate in Pregnant Women.
    Zhang X; Luo T; Yang H; Ma WY; He Q; Xu M; Yang Y
    Curr Drug Metab; 2023; 23(14):1115-1123. PubMed ID: 36718061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Physiologically Based Pharmacokinetic Model for Pregnant Women to Predict the Pharmacokinetics of Drugs Metabolized Via Several Enzymatic Pathways.
    Dallmann A; Ince I; Coboeken K; Eissing T; Hempel G
    Clin Pharmacokinet; 2018 Jun; 57(6):749-768. PubMed ID: 28924743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-depth analysis of patterns in selection of different physiologically-based pharmacokinetic modeling tools: Part II - Assessment of model reusability and comparison between open and non-open source-code software.
    Aldibani HKA; Rajput AJ; Rostami-Hodjegan A
    Biopharm Drug Dispos; 2023 Aug; 44(4):292-300. PubMed ID: 37083940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality Assurance of PBPK Modeling Platforms and Guidance on Building, Evaluating, Verifying and Applying PBPK Models Prudently under the Umbrella of Qualification: Why, When, What, How and By Whom?
    Frechen S; Rostami-Hodjegan A
    Pharm Res; 2022 Aug; 39(8):1733-1748. PubMed ID: 35445350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary physiologically based pharmacokinetic modeling of renally cleared drugs in Chinese pregnant women.
    Song L; Yu Z; Xu Y; Li X; Liu X; Liu D; Zhou T
    Biopharm Drug Dispos; 2020 Jun; 41(6):248-267. PubMed ID: 32520400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of physiologically based pharmacokinetic modeling to predict drug disposition in pregnant populations.
    Jogiraju VK; Avvari S; Gollen R; Taft DR
    Biopharm Drug Dispos; 2017 Oct; 38(7):426-438. PubMed ID: 28474821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiological-based pharmacokinetic modeling trends in pharmaceutical drug development over the last 20-years; in-depth analysis of applications, organizations, and platforms.
    El-Khateeb E; Burkhill S; Murby S; Amirat H; Rostami-Hodjegan A; Ahmad A
    Biopharm Drug Dispos; 2021 Apr; 42(4):107-117. PubMed ID: 33325034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of physiological changes during the postpartum period into a PBPK framework and prediction of amoxicillin disposition before and shortly after delivery.
    Dallmann A; Himstedt A; Solodenko J; Ince I; Hempel G; Eissing T
    J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):341-359. PubMed ID: 32748112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically-based pharmacokinetic modeling of renally excreted antiretroviral drugs in pregnant women.
    De Sousa Mendes M; Hirt D; Urien S; Valade E; Bouazza N; Foissac F; Blanche S; Treluyer JM; Benaboud S
    Br J Clin Pharmacol; 2015 Nov; 80(5):1031-41. PubMed ID: 26011128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiologically-based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate.
    Mahdy WYB; Yamamoto K; Ito T; Fujiwara N; Fujioka K; Horai T; Otsuka I; Imafuku H; Omura T; Iijima K; Yano I
    Clin Transl Sci; 2023 Apr; 16(4):618-630. PubMed ID: 36655374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Drugs Pharmacotherapy During Pregnancy Using Physiologically Based Pharmacokinetic Models - An Update.
    Alsmadi MM; Idkaidek N
    Curr Drug Metab; 2018; 19(12):972-978. PubMed ID: 29962340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.